Archives
HCQ Protects Against Cyclophosphamide Ovarian Failure
2026-08-11
This Research Square preprint reports that hydroxychloroquine partially protects mice and cultured granulosa cells from cyclophosphamide-associated ovarian injury by reducing mitochondrial dysfunction, mtDNA leakage, cGAS-STING activation, and cellular senescence. The work provides a mechanistic framework for investigating granulosa-cell preservation, while its preclinical design means that clinical efficacy and optimal treatment parameters remain unresolved.
Vidarabine Monohydrate: Antiviral Assay Workflows
2026-08-11
Build more reliable antiviral experiments with a DMSO-first formulation strategy, matched vehicle controls, and orthogonal measurements of viral replication and cell health. This guide shows how Vidarabine monohydrate can support herpes simplex virus research while adapting a screening logic from a distinct molecular pharmacology study without overstating cross-domain evidence.
Tunable Human Intestinal Organoids: Study Insights
2026-08-10
A 2025 Nature Communications study establishes a human small intestinal organoid system that better balances stem-cell self-renewal, proliferation, and multilineage differentiation under a single culture condition. Its combination of stemness enhancement, reversible BET-dependent fate shifting, and Wnt, Notch, or BMP niche-signal manipulation offers a scalable framework for organoid biology and high-throughput research.
2-Thio-dCTP Workflows for Precise DNA Studies
2026-08-09
2-Thio-dCTP enables controlled sulfur substitution in DNA synthesis for polymerase specificity testing, site-specific DNA modification, and DNA–protein interaction studies. This practical guide connects reagent handling with assay design, chromatin-focused interpretation, and troubleshooting strategies.
Arachidonic Acid in Stroke Inflammation Assays
2026-08-08
Arachidonic Acid gives researchers a controllable entry point into eicosanoid biosynthesis, oxidative stress, and barrier-injury workflows. This guide connects lipid mediator profiling with the selective hypothermic albumin strategy reported in a rat stroke model while keeping experimental claims and practical recommendations clearly separated.
Hypoxia and Immunometabolism in Tumors
2026-08-07
This 2025 review frames tumor hypoxia and immunometabolism as a reciprocal system in which oxygen shortage, nutrient competition, and immune-cell dysfunction reinforce an immunosuppressive tumor microenvironment. Its practical contribution is a mechanistic framework for designing metabolism-aware tumor models and for evaluating hypoxia- or immunometabolism-directed therapeutic strategies.
Safeguarding Protein Integrity in Starvation-Driven LD Resea
2026-08-07
This article explores how mechanistic insights into DFCP1-mediated regulation of lipid droplet catabolism under nutrient stress create new demands for protein stability in translational research. It provides strategic, protocol-level guidance on using advanced protease inhibitor cocktails to ensure experimental reproducibility, with a focus on the APExBIO Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). The discussion bridges molecular mechanisms, validation challenges, and translational opportunities, offering a differentiated perspective for researchers navigating the complexities of lipid metabolism and protein preservation.
Dextrose (D-glucose): Reliable Solutions for Cell Viability
2026-08-06
This scenario-driven guide demonstrates how Dextrose (D-glucose) (SKU A8406) from APExBIO addresses common experimental challenges in glucose metabolism research and cell viability workflows. Evidence-backed Q&A blocks provide actionable insights for biomedical researchers, highlighting how high-purity D-glucose ensures reproducibility and sensitivity in metabolic and cytotoxicity assays.
(-)-JQ1: The Gold-Standard JQ1 Stereoisomer for BET Control
2026-08-06
(-)-JQ1, the inactive JQ1 stereoisomer, sets the benchmark for specificity in BET bromodomain inhibition studies. Its rigorous use as a negative control transforms epigenetics and cancer biology workflows, ensuring data reproducibility and clarity in BRD4-dependent cell line research.
N4-Acetylcytidine: Translational Leverage in RNA Epigenetics
2026-08-05
This thought-leadership article explores how N4-Acetylcytidine empowers translational researchers to dissect RNA modification mechanisms, refine nucleotide processing assays, and set new standards in RNA epigenetics. By synthesizing recent structural biology breakthroughs with practical workflow guidance, the piece contextualizes APExBIO’s high-purity reagent as a cornerstone for robust, reproducible, and forward-looking research.
Carvedilol in β-Adrenergic Receptor Research: Protocols & Pi
2026-08-05
Carvedilol’s unique dual antagonism and antioxidant effects empower researchers to dissect cardiovascular, vascular, and post-transplant pathways with precision. Leveraging recent insights on hematopoietic regeneration, this guide provides actionable workflows, troubleshooting strategies, and comparative context for bench scientists.
GTP Solution: Powering mRNA Therapies for Bladder Cancer
2026-08-04
This article explores the mechanistic and translational landscape of p21 mRNA–loaded lipid nanoparticles for bladder cancer, highlighting the essential role of high-purity GTP Solution (100 mM) in mRNA synthesis. We connect biological rationale, experimental advances, and practical workflow guidance for researchers aiming to accelerate RNA-based therapeutics from bench to bedside. Building on new evidence and protocol optimization, we clarify how APExBIO’s GTP Solution uniquely empowers high-fidelity mRNA generation and signal transduction research in the context of emerging bladder cancer therapies.
Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod
2026-08-04
This study dissects how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of three key alkaloids from Corydalis saxicola Bunting. The work highlights the interplay between disease state, transporter/enzyme modulation, and drug disposition, offering guidance for rational clinical dosing in MASLD/MASH therapy.
Antioxidant and α-Glucosidase Profiling of Wild vs. Cultivat
2026-08-03
This study uses UPLC-MS/MS and multiplexed in vitro assays to systematically compare the phytochemical composition and bioactivity of wild and cultivated Taihangia rupestris leaves. The findings reveal that foothill-cultivated plants possess higher flavonoid and phenolic content, resulting in superior antioxidant and α-glucosidase inhibitory activity, suggesting sustainable cultivation as a viable source of antidiabetic bioactives.
T7 RNA Polymerase: Mechanistic Precision for In Vitro RNA Sy
2026-08-03
T7 RNA Polymerase is a recombinant enzyme expressed in E. coli, exhibiting high specificity for the T7 promoter and robust RNA synthesis from linearized plasmid templates. Its precise mechanism enables high-yield in vitro transcription for research applications including RNA vaccine production and RNAi studies.
591 records 11/40 page Previous Next First page 上5页 1112131415 下5页 Last page